PropertyValue
?:abstract
  • BACKGROUND AND AIM: It is unsure whether inflammatory bowel disease (IBD) is a risk factor for novel coronavirus infection (COVID‐19). METHODS: IBD patients were identified from population‐based databases in Hong Kong and Taiwan from January 21, 2020, until April 15, 2020. RESULTS: Total 2954 and 2554 IBD patients were identified in Hong Kong and Taiwan, respectively. None had COVID‐19. Pooled analysis showed that 65.3%, 39.1%, 4.3%, and 12.8% IBD patients in Hong Kong and 75.8 %, 51.4 %, 26.1%, and 52.3 % in Taiwan were on 5‐aminosalicylates, immunomodulators, corticosteroids, and biologics, respectively. CONCLUSION: There were no reported cases of COVID‐19 infection amongst IBD patients in Hong Kong and Taiwan. IBD patients should continue their usual medications during the COVID‐19 pandemic.
?:creator
?:doi
?:doi
  • 10.1111/jgh.15164
?:journal
  • J_Gastroenterol_Hepatol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/d68cf4caccfaf59ab26cdd4b729e6c29e55f5f6d.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7361268.xml.json
?:pmcid
?:pmid
?:pmid
  • 32589798.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Zero COVID‐19 infection in inflammatory bowel disease patients: Findings from population‐based inflammatory bowel disease registries in Hong Kong and Taiwan
?:type
?:year
  • 2020-07-06

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/5p1ulo2a>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/5p1ulo2a>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all